These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22789507)

  • 1. The impact of making vaccines thermostable in Niger's vaccine supply chain.
    Lee BY; Cakouros BE; Assi TM; Connor DL; Welling J; Kone S; Djibo A; Wateska AR; Pierre L; Brown ST
    Vaccine; 2012 Aug; 30(38):5637-43. PubMed ID: 22789507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.
    Lee BY; Assi TM; Rajgopal J; Norman BA; Chen SI; Brown ST; Slayton RB; Kone S; Kenea H; Welling JS; Connor DL; Wateska AR; Jana A; Wiringa AE; Van Panhuis WG; Burke DS
    Am J Public Health; 2012 Feb; 102(2):269-76. PubMed ID: 21940923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of implementing a demand forecasting system into a low-income country's supply chain.
    Mueller LE; Haidari LA; Wateska AR; Phillips RJ; Schmitz MM; Connor DL; Norman BA; Brown ST; Welling JS; Lee BY
    Vaccine; 2016 Jul; 34(32):3663-9. PubMed ID: 27219341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
    Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
    Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.
    Assi TM; Brown ST; Djibo A; Norman BA; Rajgopal J; Welling JS; Chen SI; Bailey RR; Kone S; Kenea H; Connor DL; Wateska AR; Jana A; Wisniewski SR; Van Panhuis WG; Burke DS; Lee BY
    BMC Public Health; 2011 Jun; 11():425. PubMed ID: 21635774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
    Kristensen DD; Lorenson T; Bartholomew K; Villadiego S
    Vaccine; 2016 Feb; 34(7):899-904. PubMed ID: 26778422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmenting transport versus increasing cold storage to improve vaccine supply chains.
    Haidari LA; Connor DL; Wateska AR; Brown ST; Mueller LE; Norman BA; Schmitz MM; Paul P; Rajgopal J; Welling JS; Leonard J; Chen SI; Lee BY
    PLoS One; 2013; 8(5):e64303. PubMed ID: 23717590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of thermostable vaccines.
    Lee BY; Wedlock PT; Haidari LA; Elder K; Potet J; Manring R; Connor DL; Spiker ML; Bonner K; Rangarajan A; Hunyh D; Brown ST
    Vaccine; 2017 May; 35(23):3135-3142. PubMed ID: 28455169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removing the regional level from the Niger vaccine supply chain.
    Assi TM; Brown ST; Kone S; Norman BA; Djibo A; Connor DL; Wateska AR; Rajgopal J; Slayton RB; Lee BY
    Vaccine; 2013 Jun; 31(26):2828-34. PubMed ID: 23602666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks.
    Haidari LA; Connor DL; Wateska AR; Brown ST; Mueller LE; Norman BA; Schmitz MM; Paul P; Rajgopal J; Welling JS; Leonard J; Claypool EG; Weng YT; Chen SI; Lee BY
    J Public Health Manag Pract; 2013; 19 Suppl 2(0 2):S65-7. PubMed ID: 23903398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro array patch (MAP) for the delivery of thermostable vaccines in Australia: A cost/benefit analysis.
    Bozorgi A; Fahimnia B
    Vaccine; 2021 Oct; 39(41):6166-6173. PubMed ID: 34489130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and challenges of developing thermostable vaccines.
    Chen D; Kristensen D
    Expert Rev Vaccines; 2009 May; 8(5):547-57. PubMed ID: 19397412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine cold chain management practices in primary health centers providing an expanded immunization program in Northwest Ethiopia: self-reported and actual practice observational study.
    Ergetie FS; Kassaw AT; Sendekie AK
    Front Public Health; 2023; 11():1194807. PubMed ID: 37575101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine storage and cold chain monitoring in the North West region of Cameroon: a cross sectional study.
    Yakum MN; Ateudjieu J; Walter EA; Watcho P
    BMC Res Notes; 2015 Apr; 8():145. PubMed ID: 25884186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon.
    Ateudjieu J; Kenfack B; Nkontchou BW; Demanou M
    BMC Res Notes; 2013 Mar; 6():101. PubMed ID: 23497720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools and approaches to ensure quality of vaccines throughout the cold chain.
    Kartoglu U; Milstien J
    Expert Rev Vaccines; 2014 Jul; 13(7):843-54. PubMed ID: 24865112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries.
    Karp CL; Lans D; Esparza J; Edson EB; Owen KE; Wilson CB; Heaton PM; Levine OS; Rao R
    Vaccine; 2015 Jul; 33(30):3471-9. PubMed ID: 26055297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermostable vaccines: an innovative concept in vaccine development.
    Kumar R; Srivastava V; Baindara P; Ahmad A
    Expert Rev Vaccines; 2022 Jun; 21(6):811-824. PubMed ID: 35285366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine transport and storage: environmental challenges.
    Zaffran M
    Dev Biol Stand; 1996; 87():9-17. PubMed ID: 8853997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.